Pitsava, Georgia
Faucz, Fabio R. http://orcid.org/0000-0001-7959-9842
Stratakis, Constantine A.
Hannah-Shmouni, Fady
Article History
Accepted: 7 June 2022
First Online: 16 July 2022
Compliance with Ethical Standards
:
: Dr. Hannah-Shmouni is a member of the Endocrine Hypertension Subcommittee of the Canadian Hypertension Guidelines (Hypertension Canada) and has no relevant disclosures to report. Dr. Stratakis holds patents on the <i>PRKAR1A</i>, <i>PDE11A</i>, and <i>GPR101</i> genes and/or their function and has received research funding from Pfizer Inc. on the genetics and treatment of abnormalities of growth hormone secretion. Dr. Stratakis is currently employed by ELPEN Pharmaceuticals and has received consulting fees from Sync, Lundbeck, and Sandoz. Dr. Stratakis also reports grant support from the NIH. Dr. Faucz holds a patent on the <i>GPR101</i> gene and its function. Dr. Pitsava has no conflicts of interest.
: This article does not contain any new human or animal trial study results.